Intervention

ESK981

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions12

Lead sponsors shown2

Clinical trials

2 shown

Multicenter Trial of ESK981 in Patients With Select Solid TumorsNCT05988918 · 2024-04-19

ACTIVE_NOT_RECRUITING

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate CancerNCT03456804 · 2018-03-08

Common conditions

Adenosquamous Carcinoma1 Castration Levels of Testosterone1 Castration-Resistant Prostate Carcinoma1 Gastrointestinal Neuroendocrine Carcinoma1 Gastrointestinal Neuroendocrine Tumor1 Metastatic Prostate Carcinoma1 Neuroendocrine Prostate Carcinoma1 Pancreatic Adenocarcinoma1 Pancreatic Neuroendocrine Carcinoma1 Pancreatic Neuroendocrine Tumor1 PSA Progression1 Stage IV Prostate Adenocarcinoma AJCC v71

Leading sponsors

Barbara Ann Karmanos Cancer Institute1 University of Michigan Rogel Cancer Center1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.